Exchange: NYSE·Updated 07:30 PM EDT
News
all
press releases
If You Invested $100 In Cigna Group Stock 20 Years Ago, You Would Have This Much Today
Cigna Group (NYSE:CI) has outperformed the market over the past 20 years by 1.31% on an annualized basis producing an average annual return of 10.57%. Currently, Cigna Group has a market capitalization of $75.26read more...
Benzinga
More News
Here's Why Cigna (CI) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
If You Invested $1000 In Cigna Group Stock 20 Years Ago, You Would Have This Much Today
Cigna Group (NYSE:CI) has outperformed the market over the past 20 years by 1.25% on an annualized basis producing an average annual return of 10.49%. Currently, Cigna Group has a market capitalization of $73.46read more...
Benzinga
Can Cigna's Smart Coverage Help Close Health-Cost Gaps?
CI's Smart Coverage links medical and supplemental benefits, offering up to $7,000 and automated claims for costly health events.
Zacks
Cigna Healthcare Connects Medical and Supplemental Benefits To Help People Better Manage Unexpected Health Costs
Cigna Healthcare Connects Medical and Supplemental Benefits To Help People Better Manage Unexpected Health Costs Cigna Healthcare Connects Medical and Supplemental Benefits To Help People Better Manage Unexpected Health Costs PR Newswire BLOOMFIELD, Conn., Aug. 26, 2026 Industry-first connected...
PR Newswire
Zacks Industry Outlook UnitedHealth, The Cigna, Humana, Centene and Molina
UnitedHealth, The Cigna, Humana, Centene and Molina have been highlighted in this Industry Outlook article.
Zacks
5 HMO Stocks to Watch Amid Steady Premium Flow, Increased Digitization
An aging U.S. population, digital transformation, a diversified membership mix and strategic M&A are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
Zacks
Cigna (CI) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
Here's Why Investors Should Stay Neutral on Cigna Stock for Now
CI's growth and shareholder returns are weighed against rising costs, medical expenses and debt, keeping investors neutral for now.
Zacks
Is CVS Stock a Buy as Earnings Improve but Key Risks Remain Elevated?
CVS Health enters the second half of 2026 with stronger earnings and Aetna gains, but medical costs and Caremark risks cloud the recovery.
Zacks

Advertisement|Remove ads.